Of the children with T1DM, 52% (n = 62) used injection pens; of those 62 patients, 6% (n = 4) also received continuous glucose monitoring (CGM), and the other 94% (n = 58) received only human recombinant insulin (Humulin R). The gene discussed is INS; the disease is type 1 diabetes mellitus.